Skip to main content
Livermore
Livermore
ZHEN

Great Diamond Partners, LLC

SEC CIK
0001801112
Latest filing
Jul 17, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Great Diamond Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,346
Value
$668.6K
% of portfolio
0.1%
Quarters held
20
Since Q3 2021
Holdings of VRTX by Great Diamond Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,346$668.6K0.1%−58−4.1%ReducedHolders
Q1 20261,404$626.9K0.1%−12−0.8%ReducedHolders
Q4 20251,416$642.0K0.1%+44+3.2%AddedHolders
Q3 20251,372$537.3K0.1%−404−22.7%ReducedHolders
Q2 20251,776$790.7K0.2%+423+31.3%AddedHolders
Q1 20251,353$656.0K0.2%+338+33.3%AddedHolders
Q4 20241,015$408.7K0.1%−12−1.2%ReducedHolders
Q3 20241,027$477.6K0.1%−682−39.9%ReducedHolders
Q2 20241,709$801.0K0.2%−34−2.0%ReducedHolders
Q1 20241,743$728.6K0.2%−16−0.9%ReducedHolders
Q4 20231,759$715.7K0.2%+21+1.2%AddedHolders
Q3 20231,738$604.4K0.2%+1+0.1%AddedHolders
Q2 20231,737$611.3K0.2%+139+8.7%AddedHolders
Q1 20231,598$503.5K0.1%−203−11.3%ReducedHolders
Q4 20221,801$520.1K0.2%−116−6.1%ReducedHolders
Q3 20221,917$555.0K0.2%−83−4.2%ReducedHolders
Q2 20222,000$563.0K0.2%−483−19.5%ReducedHolders
Q1 20222,483$647.0K0.2%−153−5.8%ReducedHolders
Q4 20212,636$578.0K0.1%−38−1.4%ReducedHolders
Q3 20212,674$485.0K0.1%+2,674NewHolders